The World Health Organisation (WHO) has added Pediatric Zinc Sulphate Tablet (20mg dispersible tablet) manufactured by Swiss Pharma (SWIPHA) Nigeria Limited, to its list of Pre-Qualified medicines.
The director-general, National Agency for Food and Drug Administration and Control (NAFDAC), Prof. Mojisola Christianah Adeyeye, who disclosed this in a press briefing on Tuesday, in Lagos, said this laudable feat is the outcome of meaningful collaboration between the Swiss Pharma Nigeria Limited and NAFDAC.
Every year, billions of dollars worth of medicines are purchased by or through international procurement agencies for distribution in resources-limited countries. The advantages of having a Pre-Pre-qualification (PQ) in terms of trade cannot be overemphasized, the DG averred, adding that it helps to ensure that medicines supplied by procurement agencies meet acceptable standards of quality, safety and efficacy.
„WHO‘s PQ is the fundamental prerequisite for quality assurance of key medical products to be purchased by UN agencies, Global Funds and United States Agency for International Development (USAID). Today, SWIPHA has this opportunity. This is a new source of business and it will generate foreign currency to the company and Nigeria.
